Search Results

Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic.

• Authors : Bizot A; Medical Oncology Department, Gustave Roussy, Villejui, France.; Karimi M

Subjects: Telemedicine*/Telemedicine*/Telemedicine*/organization & administration ; Telemedicine*/Telemedicine*/Telemedicine*/statistics & numerical data; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*therapy

• Source: British journal of cancer [Br J Cancer] 2021 Nov; Vol. 125 (11), pp. 1486-1493. Date of Electronic Publication: 2021 Sep 29.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability.

• Authors : Crocetti E; De Angelis R ...

Subjects: Neoplasms/Neoplasms/Neoplasms/*epidemiology ; Neoplasms/Neoplasms/Neoplasms/*mortality; Age Distribution

• Source: British journal of cancer [Br J Cancer] 2013 Jul 09; Vol. 109 (1), pp. 219-28. Date of Electronic Publication: 2013 Jun 25.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

Record details

The Mesothelioma epidemic in Western Europe: an update.

• Authors : Pelucchi C; Istituto di Ricerche Farmacologiche 'Mario Negri', Via Eritrea 62, Milano 20157, Italy. ; Malvezzi M

Subjects: Mesothelioma/Mesothelioma/Mesothelioma/*epidemiology ; Pleural Neoplasms/Pleural Neoplasms/Pleural Neoplasms/*epidemiology; Adult

• Source: British journal of cancer [Br J Cancer] 2004 Mar 08; Vol. 90 (5), pp. 1022-4.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium:

Record details

CALENDAR.

Subjects: *CONFERENCES & conventions; *ONCOLOGY conferencesITALY; PARIS (France); FRANCE

• Source: British Journal of Cancer. 3/15/2000, Vol. 82 Issue 6, p1246. 1p.

Record details

Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinib.

• Authors : Mickisch, G.; Gore, M.; Escudier, B.

Subjects: RENAL cell carcinoma; BEVACIZUMAB; INTERFERONSFRANCE; GERMANY; ITALY

• Source: British Journal of Cancer; 1/4/2010, Vol. 102 Issue 1, p80-86, 7p, 2 Charts, 3 Graphs

Record details